TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CEEK-CURE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CEEK-CURE

ST13

US500000079328043

Classe

9, 42

Pedido

79328043

Registro

7088818

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

28

Atualização mais recente

16/10/2023

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 42

Data de depósito

26/10/2021

Data de registro

27/06/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

27/06/2023

Última transação

27/06/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

KR

Examinador

SPARACINO, MARK V

Unidade examinadora

L30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Cimplrx Co., Ltd.

Representantes

Boris Umansky Ladas & Parry LLP

Classificação técnica

Classes Nice

Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable computer software for drug discovery; downloadable computer programs for drug discovery; downloadable computer software for diagnosing diseases for medical purposes; recorded computer software for drug discovery; recorded computer programs for drug discovery; recorded computer software for diagnosing diseases for medical purposes; downloadable data processing software; recorded data processing software; downloadable computer software to enable searching of data; recorded computer software to enable searching of data; downloadable database management software applications; downloadable computer software for creating searchable databases; recorded computer software for creating searchable databases; downloadable computer software for accessing information directories that may be downloaded from the global computer network; recorded computer software for accessing information directories that may be downloaded from the global computer network; downloadable computer software for use in providing multiple user access to a global computer information network; recorded computer software for use in providing multiple user access to a global computer information network; downloadable computer operating system software; recorded computer operating system software

Classe 42

New pharmaceutical research and development; drug discovery services; conducting early evaluations in the field of new pharmaceuticals; research relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; laboratory research in the field of pharmaceuticals; research and development of vaccines and medicines; medicine research; providing information on research and development of new products, namely, information on the testing, inspection, and research of medical products; scientific research in the field of pharmaceuticals; scientific research in the fields of biomedicine; development of computer software for drug discovery; development and creation of computer programmes for data processing; providing online non downloadable software for drug discovery; providing online non downloadable software for drug discovery; providing online non downloadable software for diagnosing diseases for medical purposes; providing online non downloadable software for processing, searching, and creating data; providing online non downloadable software for accessing information directories that may be downloaded from the global computer network; providing online non downloadable software for use in providing multiple user access to a global computer information network; rental of software for drug discovery; updating and adapting of computer programs according to user requirements; software as a service (SaaS) featuring software for drug discovery; software as a service (SaaS) featuring software for diagnosing diseases for medical purposes; software as a service (SaaS) featuring software for processing, searching, and creating data; software as a service (SaaS) featuring software for accessing information directories that may be downloaded from the global computer network; software as a service (SaaS) featuring software for use in providing multiple user access to a global computer information network; providing PaaS (platform as a service) featuring software for drug discovery; providing PaaS (platform as a service) featuring software for diagnosing diseases for medical purposes; providing PaaS (platform as a service) featuring software for processing, searching, and creating data; providing PaaS (platform as a service) featuring software for accessing information directories that may be downloaded from the global computer network; providing PaaS (platform as a service) featuring software for use in providing multiple user access to a global computer information network

Publicações

Histórico de despachos e eventos da marca no USPTO.

28 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

16/10/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

27/09/2023

FIMP

FINAL DISPOSITION PROCESSED

27/09/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

27/09/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

27/06/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

27/06/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

30/05/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/05/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

10/05/2023

GPNX

NOTIFICATION PROCESSED BY IB

12/04/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/04/2023

PUBO

PUBLISHED FOR OPPOSITION

11/04/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

22/03/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

22/03/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

22/03/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/03/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

14/02/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/02/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/02/2023

RFNT

REFUSAL PROCESSED BY IB

05/09/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

18/08/2022

RFRR

REFUSAL PROCESSED BY MPU

18/08/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

27/07/2022

CNRT

NON-FINAL ACTION WRITTEN

26/07/2022

DOCK

ASSIGNED TO EXAMINER

21/07/2022

MAFR

APPLICATION FILING RECEIPT MAILED

14/12/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/12/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/12/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CEEK-CURE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.